Please enable JavaScript to continue using this application.

Compare $CLNN vs $GOSS | Chartloom

Compare

$CLNN vs $GOSS

Clene Inc · Gossamer Bio Inc

CLNN

Clene Inc

GOSS

Gossamer Bio Inc

Compare $CLNN vs $GOSS

Comparing Clene Inc and Gossamer Bio Inc

CLNNClene Inc

GOSSGossamer Bio Inc

CLNNClene Inc

Market cap

$49M

P/E (TTM)

—

Forward P/E (NTM)

—

Forward P/S (NTM)

176.51x

Rev growth (TTM)

-31.1%

YTD performance

-33.1%

52W performance

-59.0%

FCF yield

-32.3%

GOSSGossamer Bio Inc

Market cap

$4.55B

P/E (TTM)

—

Forward P/E (NTM)

—

Forward P/S (NTM)

—

Rev growth (TTM)

32.4%

YTD performance

-96.0%

52W performance

-95.2%

FCF yield

-3.6%

Add ticker

Add up to 1 more ticker to compare

Relative performance

Each ticker starts at 100. 110 means +10% from the start of this window — not a $110 share price.

CLNN

GOSS

Detailed metrics comparison

CLNN

Clene Inc

GOSS

Gossamer Bio Inc

Market Cap

CLNN$49M

GOSS$4.55B

Enterprise Value

CLNN$58M

GOSS$4.55B

Price

CLNN$3.86

GOSS$9.31

P/E Ratio

CLNNN/A

GOSSN/A

P/S Ratio

CLNN250.41x

GOSS85.41x

EV/Sales

CLNN296.36x

GOSS85.32x

EV/EBITDA

CLNN0.00x

GOSS0.00x

P/B Ratio

CLNN13.60x

GOSS2.26x

P/FCF Ratio

CLNNN/A

GOSSN/A

EV/FCF

CLNN-3.66x

GOSS-27.95x

PEG Ratio

CLNNN/A

GOSSN/A

Forward P/E (NTM)

CLNNN/A

GOSSN/A

Forward P/S (NTM)

CLNN176.51x

GOSSN/A

Revenue (TTM)

CLNN$197K

GOSS$53M

Revenue Growth (YoY)

CLNN-31.1%

GOSS32.4%

Forward Rev Growth

CLNN10485.4%

GOSS50.5%

Gross Margin (TTM)

CLNN70.1%

GOSS0.0%

Operating Margin (TTM)

CLNN0.0%

GOSS0.0%

EBITDA Margin (TTM)

CLNN-9704.6%

GOSS-297.6%

Net Margin (TTM)

CLNN-20059.9%

GOSS-235.0%

FCF Margin (TTM)

CLNN-8094.9%

GOSS-305.2%

Net Income (TTM)

CLNN$-40M

GOSS$-125M

FCF (TTM)

CLNN$-16M

GOSS$-163M

EPS (TTM)

CLNN-$3.19

GOSS-$0.38

ROE (TTM)

CLNN-32223.0%

GOSS-11877.0%

ROA (TTM)

CLNN-18564.0%

GOSS-8535.0%

ROIC (TTM)

CLNN-11721.0%

GOSS-2300.0%

Cash

CLNN$10M

GOSS$41M

Debt

CLNN$19M

GOSS$36M

Net Cash/Debt

CLNN$-9M

GOSS$5M

Current Ratio (TTM)

CLNN3.07x

GOSS0.53x

Quick Ratio (TTM)

CLNN2.91x

GOSS0.46x

Debt/Equity (TTM)

CLNN6.36x

GOSS6.83x

Debt/Assets (TTM)

CLNN0.0%

GOSS0.0%

Interest Coverage (TTM)

CLNNN/A

GOSSN/A

Net Debt/EBITDA (TTM)

CLNN0.00x

GOSS0.00x

Beta

CLNN1.06

GOSS2.28

52W Performance

CLNN-59.0%

GOSS-95.2%

YTD Performance

CLNN-33.1%

GOSS-96.0%

% from 52W High

CLNN-71.4%

GOSS-97.0%

% from 52W Low

CLNN18.8%

GOSS2.3%

Asset Turnover (TTM)

CLNN0.01x

GOSS0.36x

FCF Yield (TTM)

CLNN-32.3%

GOSS-3.6%

Earnings Yield (TTM)

CLNN-80.1%

GOSS-2.8%

Dividend Yield (TTM)

CLNNN/A

GOSSN/A

Rule of 40

CLNN-8,126.0

GOSS-272.8

EV/GP/RG

CLNN10.10

GOSSN/A

Ticker research

View CLNN research View GOSS research

Metric	CLNN Clene Inc	GOSS Gossamer Bio Inc
Market & Valuation
Market Cap	$49M	$4.55B
Enterprise Value	$58M	$4.55B
Price	$3.86	$9.31
P/E Ratio	N/A	N/A
P/S Ratio	250.41x	85.41x
EV/Sales	296.36x	85.32x
EV/EBITDA	0.00x	0.00x
P/B Ratio	13.60x	2.26x
P/FCF Ratio	N/A	N/A
EV/FCF	-3.66x	-27.95x
PEG Ratio	N/A	N/A
Forward P/E (NTM)	N/A	N/A
Forward P/S (NTM)	176.51x	N/A
Revenue & Growth
Revenue (TTM)	$197K	$53M
Revenue Growth (YoY)	-31.1%	32.4%
Forward Rev Growth	10485.4%	50.5%
Profitability
Gross Margin (TTM)	70.1%	0.0%
Operating Margin (TTM)	0.0%	0.0%
EBITDA Margin (TTM)	-9704.6%	-297.6%
Net Margin (TTM)	-20059.9%	-235.0%
FCF Margin (TTM)	-8094.9%	-305.2%
Net Income (TTM)	$-40M	$-125M
FCF (TTM)	$-16M	$-163M
EPS (TTM)	-$3.19	-$0.38
ROE (TTM)	-32223.0%	-11877.0%
ROA (TTM)	-18564.0%	-8535.0%
ROIC (TTM)	-11721.0%	-2300.0%
Financial Health
Cash	$10M	$41M
Debt	$19M	$36M
Net Cash/Debt	$-9M	$5M
Current Ratio (TTM)	3.07x	0.53x
Quick Ratio (TTM)	2.91x	0.46x
Debt/Equity (TTM)	6.36x	6.83x
Debt/Assets (TTM)	0.0%	0.0%
Interest Coverage (TTM)	N/A	N/A
Net Debt/EBITDA (TTM)	0.00x	0.00x
Performance
Beta	1.06	2.28
52W Performance	-59.0%	-95.2%
YTD Performance	-33.1%	-96.0%
% from 52W High	-71.4%	-97.0%
% from 52W Low	18.8%	2.3%
Efficiency & Yields
Asset Turnover (TTM)	0.01x	0.36x
FCF Yield (TTM)	-32.3%	-3.6%
Earnings Yield (TTM)	-80.1%	-2.8%
Dividend Yield (TTM)	N/A	N/A
Other
Rule of 40	-8,126.0	-272.8
EV/GP/RG	10.10	N/A
Ticker research	View CLNN research	View GOSS research

Valuation

P/S Ratio

GOSS

85.41x

CLNN

250.41x

EV/FCF

GOSS

-27.95x

CLNN

-3.66x

Growth & revenue

Revenue Growth TTM

GOSS

32.4%

CLNN

-31.1%

Forward Revenue Growth

CLNN

10485.4%

GOSS

50.5%

Profitability & performance

Gross Margin

CLNN

70.1%

GOSS

0.0%

ROE

GOSS

-11877.0%

CLNN

-32223.0%

FCF Yield %

GOSS

-3.6%

CLNN

-32.3%

52-Week Performance

CLNN

-59.0%

GOSS

-95.2%

Detailed metrics comparison

CLNN

Clene Inc

GOSS

Gossamer Bio Inc

Market Cap

CLNN$49M

GOSS$4.55B

Enterprise Value

CLNN$58M

GOSS$4.55B

Price

CLNN$3.86

GOSS$9.31

P/E Ratio

CLNNN/A

GOSSN/A

P/S Ratio

CLNN250.41x

GOSS85.41x

EV/Sales

CLNN296.36x

GOSS85.32x

EV/EBITDA

CLNN0.00x

GOSS0.00x

P/B Ratio

CLNN13.60x

GOSS2.26x

P/FCF Ratio

CLNNN/A

GOSSN/A

EV/FCF

CLNN-3.66x

GOSS-27.95x

PEG Ratio

CLNNN/A

GOSSN/A

Forward P/E (NTM)

CLNNN/A

GOSSN/A

Forward P/S (NTM)

CLNN176.51x

GOSSN/A

Revenue (TTM)

CLNN$197K

GOSS$53M

Revenue Growth (YoY)

CLNN-31.1%

GOSS32.4%

Forward Rev Growth

CLNN10485.4%

GOSS50.5%

Gross Margin (TTM)

CLNN70.1%

GOSS0.0%

Operating Margin (TTM)

CLNN0.0%

GOSS0.0%

EBITDA Margin (TTM)

CLNN-9704.6%

GOSS-297.6%

Net Margin (TTM)

CLNN-20059.9%

GOSS-235.0%

FCF Margin (TTM)

CLNN-8094.9%

GOSS-305.2%

Net Income (TTM)

CLNN$-40M

GOSS$-125M

FCF (TTM)

CLNN$-16M

GOSS$-163M

EPS (TTM)

CLNN-$3.19

GOSS-$0.38

ROE (TTM)

CLNN-32223.0%

GOSS-11877.0%

ROA (TTM)

CLNN-18564.0%

GOSS-8535.0%

ROIC (TTM)

CLNN-11721.0%

GOSS-2300.0%

Cash

CLNN$10M

GOSS$41M

Debt

CLNN$19M

GOSS$36M

Net Cash/Debt

CLNN$-9M

GOSS$5M

Current Ratio (TTM)

CLNN3.07x

GOSS0.53x

Quick Ratio (TTM)

CLNN2.91x

GOSS0.46x

Debt/Equity (TTM)

CLNN6.36x

GOSS6.83x

Debt/Assets (TTM)

CLNN0.0%

GOSS0.0%

Interest Coverage (TTM)

CLNNN/A

GOSSN/A

Net Debt/EBITDA (TTM)

CLNN0.00x

GOSS0.00x

Beta

CLNN1.06

GOSS2.28

52W Performance

CLNN-59.0%

GOSS-95.2%

YTD Performance

CLNN-33.1%

GOSS-96.0%

% from 52W High

CLNN-71.4%

GOSS-97.0%

% from 52W Low

CLNN18.8%

GOSS2.3%

Asset Turnover (TTM)

CLNN0.01x

GOSS0.36x

FCF Yield (TTM)

CLNN-32.3%

GOSS-3.6%

Earnings Yield (TTM)

CLNN-80.1%

GOSS-2.8%

Dividend Yield (TTM)

CLNNN/A

GOSSN/A

Rule of 40

CLNN-8,126.0

GOSS-272.8

EV/GP/RG

CLNN10.10

GOSSN/A

Ticker research

View CLNN research View GOSS research

Metric	CLNN Clene Inc	GOSS Gossamer Bio Inc
Market & Valuation
Market Cap	$49M	$4.55B
Enterprise Value	$58M	$4.55B
Price	$3.86	$9.31
P/E Ratio	N/A	N/A
P/S Ratio	250.41x	85.41x
EV/Sales	296.36x	85.32x
EV/EBITDA	0.00x	0.00x
P/B Ratio	13.60x	2.26x
P/FCF Ratio	N/A	N/A
EV/FCF	-3.66x	-27.95x
PEG Ratio	N/A	N/A
Forward P/E (NTM)	N/A	N/A
Forward P/S (NTM)	176.51x	N/A
Revenue & Growth
Revenue (TTM)	$197K	$53M
Revenue Growth (YoY)	-31.1%	32.4%
Forward Rev Growth	10485.4%	50.5%
Profitability
Gross Margin (TTM)	70.1%	0.0%
Operating Margin (TTM)	0.0%	0.0%
EBITDA Margin (TTM)	-9704.6%	-297.6%
Net Margin (TTM)	-20059.9%	-235.0%
FCF Margin (TTM)	-8094.9%	-305.2%
Net Income (TTM)	$-40M	$-125M
FCF (TTM)	$-16M	$-163M
EPS (TTM)	-$3.19	-$0.38
ROE (TTM)	-32223.0%	-11877.0%
ROA (TTM)	-18564.0%	-8535.0%
ROIC (TTM)	-11721.0%	-2300.0%
Financial Health
Cash	$10M	$41M
Debt	$19M	$36M
Net Cash/Debt	$-9M	$5M
Current Ratio (TTM)	3.07x	0.53x
Quick Ratio (TTM)	2.91x	0.46x
Debt/Equity (TTM)	6.36x	6.83x
Debt/Assets (TTM)	0.0%	0.0%
Interest Coverage (TTM)	N/A	N/A
Net Debt/EBITDA (TTM)	0.00x	0.00x
Performance
Beta	1.06	2.28
52W Performance	-59.0%	-95.2%
YTD Performance	-33.1%	-96.0%
% from 52W High	-71.4%	-97.0%
% from 52W Low	18.8%	2.3%
Efficiency & Yields
Asset Turnover (TTM)	0.01x	0.36x
FCF Yield (TTM)	-32.3%	-3.6%
Earnings Yield (TTM)	-80.1%	-2.8%
Dividend Yield (TTM)	N/A	N/A
Other
Rule of 40	-8,126.0	-272.8
EV/GP/RG	10.10	N/A
Ticker research	View CLNN research	View GOSS research